Inspect What You Expect

Garofano, Christina; Heckelman, Wendy
March 2011
Pharmaceutical Representative;Mar2011, Vol. 41 Issue 3, p30
In this article, the authors discuss the benefits of adopting field-based monitoring (FBM) programs in the biopharmaceutical industry. They note that FBM can monitor sales performance and compliance standards, helping companies avoid damaging prosecutions and fines. They point out that an FBM program offers value to compliance and sales organizations by creating behavioral standards, providing behavioral based training, and combining efforts with real time reporting and follow-up procedures.


Related Articles

  • Chapter 2: Definitions and Concepts. Patzelt, Holger; Schweizer, Lars; Behrens, Judith // Foundations & Trends in Entrepreneurship;2012, Vol. 8 Issue 2, p68 

    Chapter 2 of the book "Foundations & Trends in Entrepreneurship," by Holger Patzelt, Lars Schweizer and Judith Behrens is presented. It presents the classification of biotechnology firms (BTF) and explains the method for business management for biopharmaceutical industries. It mentions the...

  • Chinese hamster genome sequenced from sorted chromosomes. Brinkrolf, Karina; Rupp, Oliver; Laux, Holger; Kollin, Florian; Ernst, Wolfgang; Linke, Burkhard; Kofler, Rudolf; Romand, Sandrine; Hesse, Friedemann; Budach, Wolfgang E; Galosy, Sybille; Müller, Dethardt; Noll, Thomas; Wienberg, Johannes; Jostock, Thomas; Leonard, Mark; Grillari, Johannes; Tauch, Andreas; Goesmann, Alexander; Helk, Bernhard // Nature Biotechnology;Aug2013, Vol. 31 Issue 8, p694 

    The article offers information on Chinese hamster ovary (CHO)-K1 cells, the most frequently used mammalian production cell line for biopharmaceutical products and industry. It states that Chinese hamster genome can now be sequenced from sorted chromosomes. It further mentions effects of...

  • Aseptic Validation in Single-Use Technology. Bhella, Richard; Pethe, Vishwas // Contract Pharma;Apr2013, Vol. 15 Issue 3, p68 

    The article focuses on the use of aseptic validation in single-use technologies, which is offering a solution for biopharma manufacturers. The quality checks for the validation of aseptic integrity include the visual inspections and statistical burst sampling prior to bioprocess vessel or other...

  • SMART Bioprocess Design. Lee, Albert S.; Mynhier, Mark A. // Pharmaceutical Technology;Feb2011, Vol. 35 Issue 2, p32 

    The article discusses the use of a Scalable, Modeled, Adaptive, Rational, and Tested (SMART) biomanufacturing processes for follow-on biologics companies. According to the author, to realize the potential of SMART bioprocesses in identifying major classes of drugs, companies must acquire more...

  • Helium Integrity Testing of Single-Use vessels. Pethe, Vishwas; Terentiev, Alex // Pharmaceutical Technology Europe;Oct2013, Vol. 25 Issue 10, p40 

    The article offers information related to the Helium integrity testing, a method to prevent failures in single-use bioprocessing vessels in biopharmaceutical industry. It mentions that the method is effective when used on small vessels. It further mentions that the accuracy level decreases when...

  • The Potential of Perfusion. Challener, Cynthia A. // Pharmaceutical Technology;Aug2015, Vol. 39 Issue 8, p36 

    The article focuses on the role of perfusion technology in the biopharmaceutical manufacturing. It mentions the well designed perfusion processing increases productivity with improved drug quality and reduces operation cost. It discusses the continuous downstream processes when integrate with...

  • 5 best practices for the independent business operator.  // Garden Center Magazine;May2012, Vol. 18 Issue 5, p98 

    The article highlights the best practices for independent business operators, such as being responsive and offering availability.

  • New Technology Showcase.  // BioPharm International;Jul2014, Vol. 27 Issue 7, p48 

    The article offers brief information on biopharmaceutical products and equipment including the bioprocess analyzer from Roche Custom Biotech, the Mobius Cell Ready 200-L bioreactor from EMD Millipore Corp. and the Advasept Technology aseptic filling solution from Catalent Inc.

  • An Enhanced Approach to Drug-Substance Development and Manufacture. Drakulich, Angie // Pharmaceutical Technology;Feb2012, Vol. 36 Issue 2, p34 

    The article discusses the provisions of the International Conference on Harmonization of Pharmaceuticals for Human Use (ICH) Q11 titled "Development and Manufacture of Drug Substance." The guideline is expected to be implemented in 2012 to enhance the concept and clarity in the description and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics